Sermorlin 5mg

Chemical Information:

• Molecular Formula: C₁₄₉H₂₄₆N₄₄O₄₂S
• Molecular Weight: 3357.88 g/mol
• Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂
• Molecular Structure: Refer to Certificate of Analysis for detailed structural information.

Description:
Sermorlin is a synthetic peptide analog of human growth hormone-releasing hormone (GHRH). Extensively studied for its potential role in stimulating endogenous secretion of growth hormone (GH), Sermorlin is frequently utilized in research involving metabolic pathways, anabolic processes, and cellular regeneration. Provided as a lyophilized powder, Sermorlin is suitable for advanced laboratory studies examining growth hormone release mechanisms, metabolic function, and tissue regeneration.

Research Applications:
Sermorlin is actively studied for potential roles in:

• Enhancing GH Secretion: Investigating mechanisms underlying natural growth hormone release from the anterior pituitary gland.
• Cellular and Tissue Repair: Exploring its role in promoting tissue healing, cellular regeneration, and recovery processes.
• Muscle and Metabolic Health: Examining effects on muscle growth, anabolic responses, and overall metabolic efficiency.
• Aging and Endocrine Research: Studying impacts on age-related decline in GH secretion and related endocrine functions.

Storage and Handling:

• Store lyophilized powder at -20°C.
• After reconstitution, refrigerate at 2-8°C and use promptly.
• Maintain aseptic handling practices to ensure sterility and product integrity.

Product Specifications:

• Purity: ≥99% (HPLC Verified)
• Appearance: Lyophilized white powder
• Solubility: Soluble in bacteriostatic water

Important Note:
This product is strictly FOR RESEARCH USE ONLY and is intended exclusively for in vitro research and laboratory experimentation by qualified professionals. It is not a drug, food, cosmetic, or dietary supplement, and has not been evaluated by the FDA. This peptide is not intended to diagnose, treat, cure, or prevent any disease. The bodily introduction into humans or animals is strictly prohibited by law. Any misuse, misbranding, or mislabeling is a violation of federal regulations and may result in legal action under applicable federal, state, or local laws.

References:
Referenced scientific publications include:

• Prakash, A., & Goa, K. L. (1999). “Sermorlin: A Review of Its Use in the Diagnosis and Treatment of Growth Hormone Deficiency.” BioDrugs.
• Merriam, G. R., et al. (2001). “Sermororlin and Growth Hormone-Releasing Hormone Analogs in the Management of Aging.” Endocrinology and Metabolism Clinics.